Compare MGNI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGNI | RGC |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | Hong Kong |
| Employees | 514 | N/A |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2014 | 2020 |
| Metric | MGNI | RGC |
|---|---|---|
| Price | $24.37 | $7.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $25.22 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 149.4K |
| Earning Date | 05-06-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 493.75 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $156,414,000.00 | N/A |
| Revenue This Year | $6.28 | N/A |
| Revenue Next Year | $9.76 | N/A |
| P/E Ratio | $153.70 | ★ N/A |
| Revenue Growth | ★ 25.45 | N/A |
| 52 Week Low | $10.82 | $4.51 |
| 52 Week High | $26.19 | $69.00 |
| Indicator | MGNI | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 62.20 | 60.05 |
| Support Level | $11.26 | $4.71 |
| Resistance Level | $25.41 | $6.75 |
| Average True Range (ATR) | 0.99 | 0.45 |
| MACD | -0.12 | 0.25 |
| Stochastic Oscillator | 64.18 | 85.56 |
Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.